Jack Mai is a seasoned professional in process development and technical operations, currently serving as Senior Manager at Beam Therapeutics since November 2021, following a managerial role in GMP Operations at Takeda from October 2019 to November 2021. With extensive experience at Dana-Farber Cancer Institute from June 2010 to October 2019, Jack excelled as a Novel Cell Processing Specialist, leading the development of phase I and II clinical trials and authoring standard operating procedures. Jack possesses strong expertise in CAR-T manufacturing and has contributed to IND submissions while overseeing various aspects of cell processing under GMP conditions. Educational credentials include a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor's degree in Cell/Cellular and Molecular Biology from Massachusetts College of Pharmacy and Health Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices